Alex Tan August 23, 2023 Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of Health said Monday, opening enrollment for the first of an array of federally-funded studies aimed at evaluating treatments for long-term symptoms still faced by many COVID-19 survivors. They will begin with a […]
Authors: MANSUR SHAHEEN DEPUTY HEALTH EDITOR FOR DAILYMAIL.COM PUBLISHED: 12:32 EST, 17 November 2022 People appear to be more likely to suffer a Covid rebound if they use Pfizer‘s antiviral drug Paxlovid, a study suggests. In the past few months, President Joe Biden, Dr Anthony Fauci and CDC director Dr Rochelle Walensky have all tested positive again quickly after they stopped taking the […]
Authors: Jim Hoft Published October 13, 2022 A new study warned that Pfizer’s Paxlovid COVID-19 pill can have harmful interactions with common medications used to treat cardiovascular disease, as what the Gateway Pundit reported in 2021. Pfizer’s Paxlovid, which contains the drugs nirmatrelvir and ritonavir (NMVr), can interact with several other drugs routinely used to treat cardiovascular […]
Virus remaining in some people’s bodies for a long time may be causing longer-term complications, recent research suggests Authors: Sumathi Reddy Sept. 8, 2022 The Wall Street Journal The virus that causes Covid-19 can remain in some people’s bodies for a long time. A growing number of scientists think that lingering virus is a root cause […]
Authors: Bart Jones August 27, 2022 Newsday Some medical experts on Long Island are disputing a new study that said Paxlovid did not help relieve COVID-19 symptoms in people under 65. Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, […]
Authors: Arielle Dreher Axios September 2, 2022 Paxlovid, once hailed as a “game-changer” for its ability to treat COVID-19 infections at home, is becoming one of the pandemic’s biggest enigmas. The intrigue: There’s growing concern about the link between Pfizer’s antiviral pill and COVID rebound, in which patients test positive or have symptoms days after a […]
Authors: Madison Muller August 25, 2022 Bloomberg Almost 40% of people hospitalized in the US with the Covid subvariant that circulated this spring were vaccinated and boosted, highlighting how new strains have mutated to more readily escape the immunity offered by current shots. The findings from scientists at the US Centers for Disease Control and […]
The Covid-19 antiviral drug can leave a foul taste. The afflicted are scouring for remedies online. Authors: Alex Janin Aug. 16, 2022 Wall Street Journal Jeanette Witten recently rummaged through her pantry for Red Hots, the cinnamon-flavored candy. The 56-year-old in Montclair, N.J., was looking for a reprieve from a persistent residual taste—“like your mouth is […]
Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]
Authors: Jack Phillips via The Epoch Times, JUN 01, 2022 Centers for Disease Control and Prevention Director Rochelle Walensky warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in symptoms. “If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday. “We haven’t yet seen anybody who has returned with symptoms needing to go […]
